Interventional Cardiology Devices | Market Insights | Europe | 2022
The mature European IC device market will be limited by declining ASPs due to a number of factors, including intense price competition. Moreover, the COVID-19 pandemic will have a negative impact on procedure volumes and market growth in 2020. However, an increasing prevalence of complex lesions and the emergence of specialized premium-priced technologies to diagnose and treat these complex CADs will mitigate these declines to some extent.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in Europe, with market projections across an 11-year period.